With a focus on severe asthma, COPD and other respiratory diseases, Aeon Respire is a therapeutics company with a patent-protected lead program under development. The approach is based on cutting edge inhalation technology and a new and differentiating mechanism of action. Management describe the firm as being "focused on a new target, a proven drug and an innovative approach for drug delivery"
